Group 1 - Han Yu Pharmaceutical (300199.SZ) released its semi-annual report for 2025 on August 22, 2025 [1] - As of August 21, 2025, seven institutional investors disclosed holdings in Han Yu Pharmaceutical A-shares, totaling 44.3541 million shares, which accounts for 5.02% of the company's total share capital [1] - The institutional investors include Shenzhen High-tech Investment Group Co., Ltd., Hong Kong Central Clearing Limited, and others, with a total institutional holding ratio decreasing by 1.61 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, two public funds reduced their holdings compared to the previous quarter, including Bosera CSI Taogold Big Data 100 A and China Merchants Stable Growth Mixed A, with a slight decrease in holding ratio [1] - One insurance fund increased its holdings, specifically Fude Property Insurance Co., Ltd. - proprietary funds, with an increase of 0.1% [1] - Foreign investment sentiment showed a decrease in holdings from one foreign fund, Hong Kong Central Clearing Limited, with a slight decline in holding ratio compared to the previous quarter [1]

8月7日，华纳药厂连续5个交易日下跌，区间累计跌幅-10.00%。湖南华纳大药厂股份有限公司成立于2001年,于2021年在上交所科创板上市(股票代 码:688799);是一家拥有多个研发中心、可对接全球创新资源,覆盖中药、化药、生物大分子药物产业链,立足中国、布局全球的创新驱动型药品生产企业。 安信医药健康股票A基金经理为池陈森。 简历显示，池陈森先生:经济学硕士。历任中投证券有限责任公司研究所研究员,上海域秀资产管理有限公司研究部研究员,中泰证券股份有限公司研究所研究 员,安信基金管理有限责任公司研究部研究员,现任安信基金管理有限责任公司研究部基金经理。 | ○ 基金经理:池陈森 | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 累计任职时间：4年又208天 | 任职起始日期：2021-01-12 现任基金公司：安信基金管理有限责任公司 | | | 基金经理简介:池陈森先生经济学硕士。历任中投证券有限责任公司研究所研究员,上海域秀 资产管理有限公司研究部研究员,中泰证券股份有限公司研究所研究员,安信基金管 ...

Group 1 - Huakang Clean (301235.SZ) released its semi-annual report for 2025 on July 30, 2025, with 10 institutional investors holding a total of 19.8267 million shares, accounting for 18.78% of the total share capital [1] - The top ten institutional investors include Sunshine Life Insurance Co., Ltd. - Dividend Insurance Product, Wuhan Kanghui Investment Management Center (Limited Partnership), and several others, with their combined holding ratio increasing by 0.56 percentage points compared to the previous quarter [1] Group 2 - In the public fund sector, one fund, Nuon An Multi-Strategy Mixed A, increased its holdings by 0.20%, while two new public funds were disclosed, including Anxin Medical Health Stock A and China Merchants CSI 1000 Index Enhanced A [2] - In the insurance capital sector, Sunshine Life Insurance Co., Ltd. - Dividend Insurance Product reduced its holdings by 1.0% compared to the previous quarter [2] - Three new foreign institutional investors were disclosed, including BARCLAYS BANK PLC, J.P. Morgan Securities PLC - proprietary funds, and Goldman Sachs LLC [2]